Global Elastomeric Infusion Pumps Market: By Product Type (Continuous Rate Elastomeric Pumps and Variable Rate Elastomeric Pumps), By Application (Pain Management, Antibiotic/Antiviral, Chemotherapy, Chelation Therapy, and Others), By End User (Hospitals, Clinics, Homecare, and Ambulatory Surgical Centers (ASC)), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Global Elastomeric Infusion Pumps Market Report Description:
Global elastomeric infusion pumps market report gives comprehensive outlook on elastomeric infusion pumps across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on elastomeric infusion pumps market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application, end user, and geographic regions. This report studies elastomeric infusion pumps market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, elastomeric infusion pumps market report includes technology advancements; regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed elastomeric infusion pumps market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the elastomeric infusion pumps market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in manufacturing, supply and usage of elastomeric infusion pumps.
Global Elastomeric Infusion Pumps Market:
Global elastomeric infusion pumps market estimated to be valued US$ 425 Mn in 2017 and poised to grow at CAGR of 6.0% over 2017-2023. Market for elastomeric infusion pumps projected to reach US$ 602 Mn by 2023 owing to increasing adoption of elastomeric infusion pumps in cancer therapy and pain management.
Market for elastomeric infusion pumps driven by rising demand across the healthcare setups
The market for elastomeric infusion pumps is driven increasing adoption of these pumps in different healthcare setups such as hospitals, clinics, homecare, and ambulatory surgical centers across the globe. The homecare market for elastomeric infusion pumps is driven by rise in usage of disposable pumps and hospital market is expected to drive the market growth significantly owing to increasing hospitalizations due to several chronic diseases which is expected to drive the pain management segment over the forecast period. Moreover, increase in adoption, growing demand for small disposable infusion pumps, and its wide range of application in various fluid drug delivery systems expected to drive the market revenue growth over the forecast period.
Technological advances expected to drive market growth positively
The technological advances in elastomeric infusion pump system offers several advantages over electronic pumps including portability, feasible demonstration, low weight, size, ease of use, and less interference with sleep, which is expected to create market demand for elastomeric infusion pumps across the globe. However, product recalls in the recent times owing to design issues expected to prompt the product manufacturers to invest in product development to address the design defects in the products, which in turn expected to drive market revenue growth positively over the forecast period
North America market leads the global elastomeric infusion pumps market
North America market leads the global elastomeric infusion pumps market and projected to remain same over the forecast period owing to reimbursement policies in the region. Europe and Asia-pacific elastomeric infusion pumps market projected to grow at significant CAGR over the forecast period in comparison with other regions
COMPETITION ASSESSMENT
Key players profiles in the global elastomeric infusion pumps market include:
KEY FINDINGS OF THE REPORT:
By Product Type
Global elastomeric infusion pumps market report gives comprehensive outlook on elastomeric infusion pumps across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on elastomeric infusion pumps market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application, end user, and geographic regions. This report studies elastomeric infusion pumps market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, elastomeric infusion pumps market report includes technology advancements; regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed elastomeric infusion pumps market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the elastomeric infusion pumps market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in manufacturing, supply and usage of elastomeric infusion pumps.
Global Elastomeric Infusion Pumps Market:
Global elastomeric infusion pumps market estimated to be valued US$ 425 Mn in 2017 and poised to grow at CAGR of 6.0% over 2017-2023. Market for elastomeric infusion pumps projected to reach US$ 602 Mn by 2023 owing to increasing adoption of elastomeric infusion pumps in cancer therapy and pain management.
Market for elastomeric infusion pumps driven by rising demand across the healthcare setups
The market for elastomeric infusion pumps is driven increasing adoption of these pumps in different healthcare setups such as hospitals, clinics, homecare, and ambulatory surgical centers across the globe. The homecare market for elastomeric infusion pumps is driven by rise in usage of disposable pumps and hospital market is expected to drive the market growth significantly owing to increasing hospitalizations due to several chronic diseases which is expected to drive the pain management segment over the forecast period. Moreover, increase in adoption, growing demand for small disposable infusion pumps, and its wide range of application in various fluid drug delivery systems expected to drive the market revenue growth over the forecast period.
Technological advances expected to drive market growth positively
The technological advances in elastomeric infusion pump system offers several advantages over electronic pumps including portability, feasible demonstration, low weight, size, ease of use, and less interference with sleep, which is expected to create market demand for elastomeric infusion pumps across the globe. However, product recalls in the recent times owing to design issues expected to prompt the product manufacturers to invest in product development to address the design defects in the products, which in turn expected to drive market revenue growth positively over the forecast period
North America market leads the global elastomeric infusion pumps market
North America market leads the global elastomeric infusion pumps market and projected to remain same over the forecast period owing to reimbursement policies in the region. Europe and Asia-pacific elastomeric infusion pumps market projected to grow at significant CAGR over the forecast period in comparison with other regions
COMPETITION ASSESSMENT
Key players profiles in the global elastomeric infusion pumps market include:
- Ambu A/S (Denmark)
- Baxter International Inc. (U.S.)
- Braun Melsungen AG (Germany)
- Fresenius Kabi AG (Germany)
- Halyard Health, Inc. (U.S.)
- Leventon S.A.U (Spain)
- Nipro Corporation (Japan)
KEY FINDINGS OF THE REPORT:
- Global elastomeric infusion pumps market expanding at 6.0% CAGR over 2017 to 2023 to reach market value of US$ 602 Mn by 2023
- Based on product type, continuous rate elastomeric pumps accounted for larger market revenue share in 2016 owing wider application in different treatments
- Hospitals are the prime buyers for the elastomeric infusion pumps across the globe and expected to remain attractive over the forecast period
- Players focusing on launching products expand market presence in global elastomeric infusion pumps market.
- The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
By Product Type
- Continuous Rate Elastomeric Pumps
- Variable Rate Elastomeric Pumps
- Pain Management
- Antibiotic/Antiviral
- Chemotherapy
- Chelation Therapy
- Others
- Hospitals
- Clinics
- Homecare
- Ambulatory Surgical Centers (ASC)
- North America
- U.S
- Canada
- Europe
- Germany
- France
- U.K
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Venezuela
- Rest of Latin America
- Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
1. RESEARCH METHODOLOGY
1.1. Secondary and Primary research
1.1.1. Secondary Sources
1.1.2. Primary Sources
1.2. Market Revenue Estimation Methodology
1.3. Key Assumptions
1.4. Acronyms
2. SCOPE OF STUDY
2.1. Market Definition
2.2. Objective of the Research
2.3. Regions covered in the study
3. EXECUTIVE SUMMARY
4. GLOBAL ELASTOMERIC INFUSION PUMPS MARKET DYNAMICS
4.1. Drivers
4.1.1. Economic Drivers
4.1.2. Demand Side Drivers
4.1.3. Supply Side Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends
5. UNIQUE FEATURES OF THE REPORT
5.1. Competition analysis
5.2. Regulatory landscape
5.3. PESTLE analysis
5.4. Porter’s analysis
6. GLOBAL ELASTOMERIC INFUSION PUMPS MARKET ANALYSIS, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Continuous Rate Elastomeric Pumps
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.2. Variable Rate Elastomeric Pumps
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7. GLOBAL ELASTOMERIC INFUSION PUMPS MARKET ANALYSIS, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Pain Management
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2. Antibiotic/Antiviral
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.3. Chemotherapy
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.4. Chelation Therapy
7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.5. Others
7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8. GLOBAL ELASTOMERIC INFUSION PUMPS MARKET FORECAST, BY END USER ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Hospitals
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.2. Clinics
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.3. Ambulatory Surgical Centers (ASC)
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.4. Homecare
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9. ELASTOMERIC INFUSION PUMPS MARKET ANALYSIS, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. North America Elastomeric Infusion Pumps Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.1.1.1. Continuous Rate Elastomeric Pumps
9.1.1.2. Variable Rate Elastomeric Pumps
9.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.1.2.1. Oral
9.1.2.2. Antibiotic/Antiviral
9.1.2.3. Chemotherapy
9.1.2.4. Chelation Therapy
9.1.2.5. Others
9.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.1.3.1. Hospital Pharmacies
9.1.3.2. Maternity Clinics
9.1.3.3. Ambulatory Surgical Centers (ASC)
9.1.3.4. Homecare
9.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.1.4.1. U.S.
9.1.4.2. Canada
9.2. Europe Elastomeric Infusion Pumps Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.2.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.2.1.1. Continuous Rate Elastomeric Pumps
9.2.1.2. Variable Rate Elastomeric Pumps
9.2.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.2.2.1. Oral
9.2.2.2. Antibiotic/Antiviral
9.2.2.3. Chemotherapy
9.2.2.4. Chelation Therapy
9.2.2.5. Others
9.2.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.2.3.1. Hospital Pharmacies
9.2.3.2. Maternity Clinics
9.2.3.3. Ambulatory Surgical Centers (ASC)
9.2.3.4. Homecare
9.2.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.2.4.1. U.K
9.2.4.2. Germany
9.2.4.3. France
9.2.4.4. Italy
9.2.4.5. Spain
9.2.4.6. Russia
9.2.4.7. Poland 9.2.4.8. Rest of Europe
9.3. Asia-Pacific Elastomeric Infusion Pumps Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.3.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.3.1.1. Continuous Rate Elastomeric Pumps
9.3.1.2. Variable Rate Elastomeric Pumps
9.3.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.3.2.1. Oral
9.3.2.2. Antibiotic/Antiviral
9.3.2.3. Chemotherapy
9.3.2.4. Chelation Therapy
9.3.2.5. Others
9.3.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.3.3.1. Hospital Pharmacies
9.3.3.2. Maternity Clinics
9.3.3.3. Ambulatory Surgical Centers (ASC)
9.3.3.4. Homecare
9.3.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.3.4.1. Japan
9.3.4.2. China
9.3.4.3. India
9.3.4.4. ASEAN
9.3.4.5. Australia & New Zealand 9.3.4.6. Rest of Asia-Pacific
9.4. Latin America Elastomeric Infusion Pumps Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.4.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.4.1.1. Continuous Rate Elastomeric Pumps
9.4.1.2. Variable Rate Elastomeric Pumps
9.4.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.4.2.1. Oral
9.4.2.2. Antibiotic/Antiviral
9.4.2.3. Chemotherapy
9.4.2.4. Chelation Therapy
9.4.2.5. Others
9.4.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.4.3.1. Hospital Pharmacies
9.4.3.2. Maternity Clinics
9.4.3.3. Ambulatory Surgical Centers (ASC)
9.4.3.4. Homecare
9.4.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.4.4.1. Brazil
9.4.4.2. Mexico
9.4.4.3. Argentina
9.4.4.4. Venezuela
9.4.4.5. Rest of Latin America
9.5. Middle East & Africa (MEA) Elastomeric Infusion Pumps Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.5.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.5.1.1. Continuous Rate Elastomeric Pumps
9.5.1.2. Variable Rate Elastomeric Pumps
9.5.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.5.2.1. Oral
9.5.2.2. Antibiotic/Antiviral
9.5.2.3. Chemotherapy
9.5.2.4. Chelation Therapy
9.5.2.5. Others
9.5.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.5.3.1. Hospital Pharmacies
9.5.3.2. Maternity Clinics
9.5.3.3. Ambulatory Surgical Centers (ASC)
9.5.3.4. Homecare
9.5.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.5.4.1. Gulf Cooperation Council (GCC) Countries
9.5.4.2. Israel
9.5.4.3. South Africa
9.5.4.4. Rest of MEA
10. COMPETITION LANDSCAPE
10.1. Strategic Dashboard of Top Market Players
10.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
10.2.1. Ambu A/S (Denmark)
10.2.2. Baxter International Inc. (U.S.)
10.2.3. Braun Melsungen AG (Germany)
10.2.4. Fresenius Kabi AG (Germany)
10.2.5. Halyard Health, Inc. (U.S.)
10.2.6. Leventon S.A.U (Spain)
10.2.7. Nipro Corporation (Japan)
1.1. Secondary and Primary research
1.1.1. Secondary Sources
1.1.2. Primary Sources
1.2. Market Revenue Estimation Methodology
1.3. Key Assumptions
1.4. Acronyms
2. SCOPE OF STUDY
2.1. Market Definition
2.2. Objective of the Research
2.3. Regions covered in the study
3. EXECUTIVE SUMMARY
4. GLOBAL ELASTOMERIC INFUSION PUMPS MARKET DYNAMICS
4.1. Drivers
4.1.1. Economic Drivers
4.1.2. Demand Side Drivers
4.1.3. Supply Side Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends
5. UNIQUE FEATURES OF THE REPORT
5.1. Competition analysis
5.2. Regulatory landscape
5.3. PESTLE analysis
5.4. Porter’s analysis
6. GLOBAL ELASTOMERIC INFUSION PUMPS MARKET ANALYSIS, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Continuous Rate Elastomeric Pumps
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
6.2. Variable Rate Elastomeric Pumps
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7. GLOBAL ELASTOMERIC INFUSION PUMPS MARKET ANALYSIS, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Pain Management
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.2. Antibiotic/Antiviral
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.3. Chemotherapy
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.4. Chelation Therapy
7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
7.5. Others
7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8. GLOBAL ELASTOMERIC INFUSION PUMPS MARKET FORECAST, BY END USER ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Hospitals
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.2. Clinics
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.3. Ambulatory Surgical Centers (ASC)
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
8.4. Homecare
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023(Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
9. ELASTOMERIC INFUSION PUMPS MARKET ANALYSIS, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. North America Elastomeric Infusion Pumps Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.1.1.1. Continuous Rate Elastomeric Pumps
9.1.1.2. Variable Rate Elastomeric Pumps
9.1.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.1.2.1. Oral
9.1.2.2. Antibiotic/Antiviral
9.1.2.3. Chemotherapy
9.1.2.4. Chelation Therapy
9.1.2.5. Others
9.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.1.3.1. Hospital Pharmacies
9.1.3.2. Maternity Clinics
9.1.3.3. Ambulatory Surgical Centers (ASC)
9.1.3.4. Homecare
9.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.1.4.1. U.S.
9.1.4.2. Canada
9.2. Europe Elastomeric Infusion Pumps Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.2.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.2.1.1. Continuous Rate Elastomeric Pumps
9.2.1.2. Variable Rate Elastomeric Pumps
9.2.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.2.2.1. Oral
9.2.2.2. Antibiotic/Antiviral
9.2.2.3. Chemotherapy
9.2.2.4. Chelation Therapy
9.2.2.5. Others
9.2.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.2.3.1. Hospital Pharmacies
9.2.3.2. Maternity Clinics
9.2.3.3. Ambulatory Surgical Centers (ASC)
9.2.3.4. Homecare
9.2.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.2.4.1. U.K
9.2.4.2. Germany
9.2.4.3. France
9.2.4.4. Italy
9.2.4.5. Spain
9.2.4.6. Russia
9.2.4.7. Poland 9.2.4.8. Rest of Europe
9.3. Asia-Pacific Elastomeric Infusion Pumps Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.3.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.3.1.1. Continuous Rate Elastomeric Pumps
9.3.1.2. Variable Rate Elastomeric Pumps
9.3.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.3.2.1. Oral
9.3.2.2. Antibiotic/Antiviral
9.3.2.3. Chemotherapy
9.3.2.4. Chelation Therapy
9.3.2.5. Others
9.3.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.3.3.1. Hospital Pharmacies
9.3.3.2. Maternity Clinics
9.3.3.3. Ambulatory Surgical Centers (ASC)
9.3.3.4. Homecare
9.3.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.3.4.1. Japan
9.3.4.2. China
9.3.4.3. India
9.3.4.4. ASEAN
9.3.4.5. Australia & New Zealand 9.3.4.6. Rest of Asia-Pacific
9.4. Latin America Elastomeric Infusion Pumps Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.4.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.4.1.1. Continuous Rate Elastomeric Pumps
9.4.1.2. Variable Rate Elastomeric Pumps
9.4.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.4.2.1. Oral
9.4.2.2. Antibiotic/Antiviral
9.4.2.3. Chemotherapy
9.4.2.4. Chelation Therapy
9.4.2.5. Others
9.4.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.4.3.1. Hospital Pharmacies
9.4.3.2. Maternity Clinics
9.4.3.3. Ambulatory Surgical Centers (ASC)
9.4.3.4. Homecare
9.4.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.4.4.1. Brazil
9.4.4.2. Mexico
9.4.4.3. Argentina
9.4.4.4. Venezuela
9.4.4.5. Rest of Latin America
9.5. Middle East & Africa (MEA) Elastomeric Infusion Pumps Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
9.5.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.5.1.1. Continuous Rate Elastomeric Pumps
9.5.1.2. Variable Rate Elastomeric Pumps
9.5.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.5.2.1. Oral
9.5.2.2. Antibiotic/Antiviral
9.5.2.3. Chemotherapy
9.5.2.4. Chelation Therapy
9.5.2.5. Others
9.5.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.5.3.1. Hospital Pharmacies
9.5.3.2. Maternity Clinics
9.5.3.3. Ambulatory Surgical Centers (ASC)
9.5.3.4. Homecare
9.5.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) and Y-o-Y Growth (%)
9.5.4.1. Gulf Cooperation Council (GCC) Countries
9.5.4.2. Israel
9.5.4.3. South Africa
9.5.4.4. Rest of MEA
10. COMPETITION LANDSCAPE
10.1. Strategic Dashboard of Top Market Players
10.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
10.2.1. Ambu A/S (Denmark)
10.2.2. Baxter International Inc. (U.S.)
10.2.3. Braun Melsungen AG (Germany)
10.2.4. Fresenius Kabi AG (Germany)
10.2.5. Halyard Health, Inc. (U.S.)
10.2.6. Leventon S.A.U (Spain)
10.2.7. Nipro Corporation (Japan)
